title: Oesophageal toxicity and hypofractionated concurrent chemoradiotherapy for non-small cell lung cancer.
authors.forename: L M
authors.initials: LM
authors.lastname: Tho
authors.forename: R
authors.initials: R
authors.lastname: Mahmood
authors.forename: M
authors.initials: M
authors.lastname: Leitch
authors.forename: I
authors.initials: I
authors.lastname: Brisbane
authors.forename: S
authors.initials: S
authors.lastname: Kakumanu
authors.forename: N
authors.initials: N
authors.lastname: Mohammed
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy / Q000532:radiotherapy*; D003131:Combined Modality Therapy; D019583:Dose Fractionation, Radiation; D004941:Esophagitis / Q000139:chemically induced / Q000209:etiology*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000532:radiotherapy*; D011832:Radiation Injuries